Melander A. (1996) Oral antidiabetic drugs: An overview. Diabetic Med 13.
Scheen A.J., Lefebvre J. (1998) Oral antidiabetic agents: A guide to selection. Drugs 55:225-236.
Malaisse W.J., Lebrun P. (1990) Mechanisms of sulfonylurea-induced insulin release. Diabetes Care 13(SUPPL. 3):9-17.
Panten U., Schwanstecher M., Schwanstecher C. (1996) Oral antidiabetics. Handbook of experimental pathology , Kuhlmann J, Puls W, editors. Berlin: Springer; 129-159.
Babenko A.P., Aguilar-Bryan L., Bryan J. (1998) A view of SUR/Kir 6.x, KATP channels. Annu Rev Physiol 60:667-687.
Ashcroft F.M., Gribble F.M. (1999) ATP-sensitive K+ channels and insulin secretion: Their role in health and disease. Diabetologia 42:903-919.
Masereel B., Lebrun P., Dogne J.M., De Tullio P., Pirotte B., Pochet L., Diouf O., Delarge J. (1996) First synthesis of 4-substituted benzenesulfonylcyanoguanidines. Tetrahedron Lett 37:7253-7254.
Masereel B., Ouedraogo R., Dogne J.M., Antoine M.-H., De Tullio P., Pirotte B., Pochet L., Delarge J., Lebrun P. (1997) Synthesis and biological evaluation of sulfonylcyanoguanidines and sulfonamidonitroethylenes as bioisosteres of hypoglycemic sulfonylureas. Eur J Med Chem 32:453-456.
Ouedraogo R., Nguyen Q.-A., Antoine M.-H., Kane C., Dunne M.J., Pochet L., Masereel B., Lebrun P. (1999) Insulinotropic effect of new glibenclamide isosteres. J Pharmacol Exp Ther 289:625-631.
Lebrun P., Antoine M.-H., Ouedraogo R., Kane C., Dunne M., Hermann M., Herchuelz A., Masereel B., Delarge J., De Tullio P., Pirotte B. (1996) Activation of ATP-dependent K+ channels and inhibition of insulin release: Effect of BPDZ 62. J Pharmacol Exp Ther 277:156-162.
Lebrun P., Malaisse W.J., Herchuelz A. (1982) Evidence for two distinct modalities of Ca2+ influx into pancreatic B cell. Am J Physiol 242.
Lebrun P., Malaisse W.J., Herchuelz A. (1985) Do hypoglycemic sulfonylureas inhibit Na+, K+-ATPase activity in pancreatic islets?. Am J Physiol 248.
Leclercq-Meyer V., Marchand J., Woussen-Colle M.C., Giroix M.H., Malaisse W.J. (1985) Multiple effects of leucine on glucagon, insulin and somatostatin secretion from the perfused rat pancreas. Endocrinology 116:1168-1174.
Pipeleers D. (1987) The biosociology of pancreatic B cells. Diabetologia 30:277-291.
Lebrun P., Atwater I. (1985) Effects of the calcium channel agonist, BAY K 8644, on electrical activity in mouse pancreatic B-cells. Biophys J 48:919-930.
Hellman B. (1981) Tolbutamide stimulation of 45Ca fluxes in microdissected pancreatic islets rich in β-cells. Mol Pharmacol 20:83-88.
Lebrun P., Malaisse W.J., Herchuelz A. (1982) Modalities of gliclazideinduced Ca2+ influx into the pancreatic B-cell. Diabetes 31:1010-1015.
Lebrun P., Malaisse W.J. (1992) Cationic and secretory effects of glimepiride and glibenclamide in perifused rat islets. Pharmacol Toxicol 70:357-360.
Malaisse W.J., Lebrun P., Sener A. (1993) Modulation of the insulinotropic action of glibenclamide and glimepiride by nutrient secretagogues in pancreatic islets from normoglycemic and hyperglycemic rats. Biochem Pharmacol 45:1845-1849.
Lebrun P., Malaisse W.J., Herchuelz A. (1982) Nutrient-induced intracellular calcium movement in rat pancreatic B cell. Am J Physiol 243.
Malaisse W.J., Lebrun P. (1993) Iterative stimulation of pancreatic islets by glipizide. Pharmacology 46:43-49.
Masereel B., Wouters J., Pochet L., Lambert D. (1998) Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes. J Med Chem 41:3239-3244.
Masereel B., Laeckmann D., Dupont L., Liegeois J.F., Pirotte B., De Tullio P., Delarge J. (1995) Synthesis and pharmacology of pyrid-3-yl sulfonylcyanoguanidines as diuretics. Eur J Med Chem 30:343-351.
Karam J.H., Sanz N., Salamon E., Nolte M.S. (1986) Selective unresponsiveness of pancreatic β-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. Diabetes 35:1314-1320.
Stenman S., Melander A., Groop P.H., Groop L.C. (1993) What is the benefit of increasing the sulfonylurea dose?. Ann Internal Med 118:169-172.
